Fig. 4From: Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligoAnalysis of gene function and metabolic pathways. a KEGG pathways demonstrated significant differences between vitiligo patients and HCs. b Galactose degradation and cysteine degradation II were identified as differential metabolic pathwaysBack to article page